New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 3, 2013
09:15 EDTSTEMStemCells spinal cord injury trial approved by Health Canada
StemCells announced that Health Canada has authorized the company to expand its Phase I/II clinical trial for chronic spinal cord injury into Canada. The Phase I/II trial, currently underway in Zurich, Switzerland, is designed to evaluate the safety and preliminary efficacy of the company's proprietary HuCNS-SC product candidate, or purified human neural stem cells, as a treatment for chronic spinal cord injury. With this authorization from Health Canada, the company is actively working to open one or more trial sites in Canada and begin screening patients.
News For STEM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 18, 2014
10:57 EDTSTEMStemCells to host analyst day
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use